Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Capital Expenditures: 2015-2024

Historic Capital Expenditures for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to $358,000.

  • Anaptysbio's Capital Expenditures fell 65.71% to $12,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $349,000, marking a year-over-year decrease of 6.93%. This contributed to the annual value of $358,000 for FY2024, which is 55.64% down from last year.
  • According to the latest figures from FY2024, Anaptysbio's Capital Expenditures is $358,000, which was down 55.64% from $807,000 recorded in FY2023.
  • In the past 5 years, Anaptysbio's Capital Expenditures ranged from a high of $1.4 million in FY2021 and a low of $358,000 during FY2022.
  • Its 3-year average for Capital Expenditures is $507,667, with a median of $358,000 in 2024.
  • Per our database at Business Quant, Anaptysbio's Capital Expenditures surged by 140.07% in 2021 and then slumped by 73.79% in 2022.
  • Anaptysbio's Capital Expenditures (Yearly) stood at $569,000 in 2020, then surged by 140.07% to $1.4 million in 2021, then slumped by 73.79% to $358,000 in 2022, then skyrocketed by 125.42% to $807,000 in 2023, then tumbled by 55.64% to $358,000 in 2024.